CN103211900A - Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica - Google Patents

Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica Download PDF

Info

Publication number
CN103211900A
CN103211900A CN2013100955520A CN201310095552A CN103211900A CN 103211900 A CN103211900 A CN 103211900A CN 2013100955520 A CN2013100955520 A CN 2013100955520A CN 201310095552 A CN201310095552 A CN 201310095552A CN 103211900 A CN103211900 A CN 103211900A
Authority
CN
China
Prior art keywords
radix
chinese medicine
sciatica
hyperosteogeny
seed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013100955520A
Other languages
Chinese (zh)
Inventor
张小文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013100955520A priority Critical patent/CN103211900A/en
Publication of CN103211900A publication Critical patent/CN103211900A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica. The traditional Chinese medicine formula includes the following medicines by weight: 40-60 g of schizonepeta seed, 15-25 g of safflower, 15-25 g of ground beeltle, 15-25 g of angelica sinensis, 20-30 g of black pepper, 20-30 g of lysimachia, 20-30 g of pepper, 15-25 g of pseudo-ginseng, 15-25 g of kudzu root, and 15-25 g of peach kernel. The raw material medicines are ground to a fine powder and mixed evenly, and then can be taken. The formula of the invention is reasonable, significant in effect, simple in preparation method. By years of clinical validation, the formula is definite and reliable, and has no toxic side effects for treatment of hyperosteogeny and sciatica. The clinical application effective rate of the present invention is 100%, and the cure rate is above 95%.

Description

A kind of Chinese medicine preparation for the treatment of hyperosteogeny and sciatica
Technical field
The present invention relates to the Chinese medicine preparation field, refer to a kind of Chinese medicine preparation for the treatment of hyperosteogeny and sciatica especially.
Background technology
Hyperosteogeny is called hyperplastic osteoarthritis, osteoarthritis (OA), degenerated arthrosis, senile arthritis, hypertrophiarthritis again, be because soft tissue degeneration, degenerations such as the cartilage in formation joint, intervertebral disc, ligaments, the edge, joint forms bony spur, variations such as synovial membrane plumpness, and osteoclasia appears, cause insecondary hyperosteogeny, cause joint deformity, when being subjected to abnormal load, cause arthralgia, a kind of disease of symptoms such as limitation of activity.Two kinds of hyperostosis constitutional estranged and Secondary cases.The traditional Chinese medical science think primary disease and wound,
Strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc. are relevant.
Sciatica is the thickest nerve of human body, originates in lumbosacral spinal cord, by way of pelvis, and passes from greater sciatic formaen, arrives at buttocks, goes downwards to foot along posterior surface of thigh then.The sensation and the motion of management lower limb are made up of lumbar nerves and sacral nerves.Be the thickest person in all nerves.Sciatic nerve goes out pelvis to buttocks through infrapiriform foramen, at gluteus maximus deeply towards descending, cross obturator internus successively, these muscle is arranged at the rear of Shang inferior gemellus muscle and quadratus femoris, and along the great adductor muscle back, descend between semitendinosus m., semimembranosus m., the biceps femoris, send flesh in the way and prop up musculus flexor to thigh, sciatic nerve Zai is before the popliteal nest, be divided into tibial nerve and common peroneal nerve, whole muscle of domination shank and foot and the shank except that saphenous nerve domination district and the dermal sensation of foot.
The medicine of the above-mentioned disease of treatment is less at present, be plaster or the prescription that adopts recipe configuration among the people mostly, and regular medicine is also undesirable at above-mentioned disease, Given this, the inventor is through the characteristic and the clinical application experience of surplus 40 years research Chinese herbal treatments, excavate the marrow of Chinese medicine characteristic treating both the principal and secondary aspects of a disease and determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, invented a kind of pure Chinese medicine preparation for the treatment of hyperosteogeny, sciatica.
Summary of the invention
Problem at existing clinical treatment the object of the present invention is to provide a kind of treatment hyperosteogeny and sciatic Chinese medicine preparation.
It is mainly developed by the former medicine of following weight: Herba Schizonepetae seed 40~60g, Flos Carthami 15~25g, Eupolyphaga Seu Steleophaga 15~25g, Radix Angelicae Sinensis 15~25g, Fructus Piperis 20~30g, Herba Lysimachiae 20~30g, Pericarpium Zanthoxyli 20~30g, Radix Notoginseng 15~25g, Radix Puerariae 15~25g, Semen Persicae 15~25g.
Preferably, Herba Schizonepetae seed 50g, Flos Carthami 20g, Eupolyphaga Seu Steleophaga 20g, Radix Angelicae Sinensis 20g, Fructus Piperis 25g, Herba Lysimachiae 25g, Pericarpium Zanthoxyli 25g, Radix Notoginseng 20g, Radix Puerariae 20g, Semen Persicae 20g.
Pharmacology analysis: 10 Chinese medicines that the present invention is selected, Herba Schizonepetae seed acrid in the mouth wherein, little hardship, property is little wet, cure mainly blood consumptive disease due to wind gas stop up full, ridge pain, sweating due to debility, tired pain of muscles and bones and YIN YANG toxin syndrome; Flos Carthami acrid in the mouth, warm in nature, GUIXIN, Liver Channel cure mainly blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain; Eupolyphaga Seu Steleophaga is salty, and is cold, cures mainly removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; The Radix Angelicae Sinensis sweet in the mouth, temperature cures mainly lumbar muscle strain, rheumatism of muscles, extremities joint sprain, arthritis, reaches sciatica, the intercostal neuralgia, occipital neuralgia; The Fructus Piperis suffering, heat cures mainly the diffusing gas of warming middle-JIAO, therapeutic method to keep the adverse QI flowing downwards pain relieving; Herba Lysimachiae sweet in the mouth, little hardship, cool in nature, cure mainly heat-clearing and toxic substances removing; Dissipating blood stasis for subsidence of swelling, traumatic injury; The Pericarpium Zanthoxyli acrid in the mouth, warm in nature, cure mainly warming middle-JIAO to relieve pain; Typhonium flagelliforme (Lodd.) Blume has another name called Typhonium flagelliforme (Lodd.) Blume and distinguishes the flavor of little sweetly and bitter, has significant significant hemopoietic function; Radix Puerariae sweet in the mouth, suffering, address pain relieving, detoxifcation, side of body wind pain; Semen Persicae bitter but sweet flavor and property are flat, cure mainly blood circulation promoting and blood stasis dispelling, the tumbling down pain of injury.The present invention just is based on the pharmacology of above-mentioned raw materials medicine, life essence-filling, marrow-benefitting, and promoting blood circulation to remove obstruction in the collateral, strengthening the tendons and bones, promoting blood circulation and stopping pain, this determined curative effect of filling a prescription, cure rate is up to 95%.
The specific embodiment
Further specify technical scheme of the present invention below by the specific embodiment:
Raw material is formed: Herba Schizonepetae seed 40~60g, Flos Carthami 15~25g, Eupolyphaga Seu Steleophaga 15~25g, Radix Angelicae Sinensis 15~25g, Fructus Piperis 20~30g, Herba Lysimachiae 20~30g, Pericarpium Zanthoxyli 20~30g, Radix Notoginseng 15~25g, Radix Puerariae 15~25g, Semen Persicae 15~25g.
Preferably, Herba Schizonepetae seed 50g, Flos Carthami 20g, Eupolyphaga Seu Steleophaga 20g, Radix Angelicae Sinensis 20g, Fructus Piperis 25g, Herba Lysimachiae 25g, Pericarpium Zanthoxyli 25g, Radix Notoginseng 20g, Radix Puerariae 20g, Semen Persicae 20g.
With above-mentioned raw materials medicine pulverization, mix homogeneously promptly gets described Chinese medicine preparation, and during use, to get 6~8g oral at every turn, sooner or later respectively once.
Also can adopt the dosage form that existing Chinese patent medicine manufacturing process is processed into other to take in addition.
The present invention fills a prescription and reaches nearly 40 years clinical treatment through the inventor, following thousand examples of user, and facts have proved has significant curative effect to clinical treatment, and effective percentage reaches very, and cure rate reaches more than 95%.
Be exemplified below:
Yang Fang: people from Nan'an District, Chongqing, 46 years old, 2002 were diagnosed as sciatica through Chongqing medical university of the army, lose the ability of normally walking, successively tossed about in bed the well-known hospitalize of national number man to 2004, it is hundreds thousand of invalid to spend, after take the medicine that this prescription is made upon somebody's introduction, adhere to one month after, can walk as the normal person, for consolidating curative effect, after adhere to month surplusly again, do not see recurrence so far.
Normal honey: Shaoyang, Hunan people from Xinshao County, 68 years old, because of rheumatism, catch cold and hyperosteogeny causes intervertebral disk hernia, be paralyzed in bed more than four months, after take the medicine that this prescription is made upon somebody's introduction, adhere to one and a half months after, effect is remarkable, recovers normal substantially, can take care of oneself.
Cheng Wei: Chenzhou, Hunan people from Yongxing County, 52 years old, because of lumbar strain, not heal for a long time, the back is attacked by cold-damp in work, causes left lower limb sciatica, and the remission of clothes pain relieving Western medicine is recurred after the drug withdrawal, and acupuncture-moxibustion, curative effect of massage are also undesirable.Begin to take the medicine that this prescription is made in May, 2008, and pain promptly disappears after 20 days, adheres to returning to one's perfect health after two months, so far not recurrence.

Claims (4)

1. Chinese medicine preparation for the treatment of hyperosteogeny and sciatica, it is characterized in that it mainly is that former medicine by following weight portion develops: Herba Schizonepetae seed 40~60g, Flos Carthami 15~25g, Eupolyphaga Seu Steleophaga 15~25g, Radix Angelicae Sinensis 15~25g, Fructus Piperis 20~30g, Herba Lysimachiae 20~30g, Pericarpium Zanthoxyli 20~30g, Radix Notoginseng 15~25g, Radix Puerariae 15~25g, Semen Persicae 15~25g.
2. according to the described prescription of claim 1, wherein the consumption of crude drug is: Herba Schizonepetae seed 50g, Flos Carthami 20g, Eupolyphaga Seu Steleophaga 20g, Radix Angelicae Sinensis 20g, Fructus Piperis 25g, Herba Lysimachiae 25g, Pericarpium Zanthoxyli 25g, Radix Notoginseng 20g, Radix Puerariae 20g, Semen Persicae 20g.
3. the preparation method of claim 1 or 2 described prescriptions, it comprises the following steps:
A) take by weighing each crude drug: Herba Schizonepetae seed 50g, Flos Carthami 20g, Eupolyphaga Seu Steleophaga 20g, Radix Angelicae Sinensis 20g, Fructus Piperis 25g, Herba Lysimachiae 25g, Pericarpium Zanthoxyli 25g, Radix Notoginseng 20g, Radix Puerariae 20g, Semen Persicae 20g, standby;
B) with described deal proportioning: Herba Schizonepetae seed, Flos Carthami, Eupolyphaga Seu Steleophaga, Radix Angelicae Sinensis, Fructus Piperis, Herba Lysimachiae, Pericarpium Zanthoxyli, Radix Notoginseng, Radix Puerariae, Semen Persicae pulverization, mix homogeneously promptly gets the Chinese medicine preparation described in the claim 1.
4. according to the described Chinese medicine preparation of claim 3, to get 6~8g during use oral at every turn, sooner or later respectively once.
CN2013100955520A 2013-03-25 2013-03-25 Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica Pending CN103211900A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013100955520A CN103211900A (en) 2013-03-25 2013-03-25 Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013100955520A CN103211900A (en) 2013-03-25 2013-03-25 Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica

Publications (1)

Publication Number Publication Date
CN103211900A true CN103211900A (en) 2013-07-24

Family

ID=48810286

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013100955520A Pending CN103211900A (en) 2013-03-25 2013-03-25 Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica

Country Status (1)

Country Link
CN (1) CN103211900A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089492A (en) * 1993-01-07 1994-07-20 孙延振 The herb medicinal paste for external application of treatment hyperosteogeny
CN101181453A (en) * 2007-11-30 2008-05-21 高伟山 Chinese medicine preparation for curing orthopaedics sickness
CN101406586A (en) * 2008-11-12 2009-04-15 宋爱民 External-use Chinese medicine preparation for treating soft tissue injury and scapulohumeral periarthritis, and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089492A (en) * 1993-01-07 1994-07-20 孙延振 The herb medicinal paste for external application of treatment hyperosteogeny
CN101181453A (en) * 2007-11-30 2008-05-21 高伟山 Chinese medicine preparation for curing orthopaedics sickness
CN101406586A (en) * 2008-11-12 2009-04-15 宋爱民 External-use Chinese medicine preparation for treating soft tissue injury and scapulohumeral periarthritis, and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103845702A (en) Traditional Chinese medicinal composition for treating irritable bowel syndrome and preparation method of composition
CN103417742A (en) Traditional Chinese medicine for curing cervical spondylosis and lumbar intervertebral disc hernia
CN102228626B (en) Traditional Chinese medicine for treating tinnitus and deafness
CN102764393B (en) A kind of medicine for the treatment of ankylosing spondylitis
CN100531762C (en) Medicine composition for treating protrusion of lumber vertebral disc and its preparation method
CN102349989A (en) Traditional Chinese medicine for treating cervical spondylosis
CN104922363A (en) Traditional Chinese medicine composite for treating osteoproliferation
CN102091169B (en) Traditional Chinese medicine capsule capable of tonifying liver and kidney, promoting blood circulation by removing blood stasis, dispelling wind, cold and dampness
CN104225283A (en) Traditional Chinese medicine for oral administration and plaster for treating cervical vertebra, scapulohumeral periarthritis, lumbar disc herniation, rheumatic arthritis and rheumatoid arthritis
CN104740208A (en) Traditional Chinese medicine preparation for treatment of prosopalgia and preparation method thereof
CN104721614A (en) Traditional Chinese medicine preparation for treating dearticulation and preparation method of traditional Chinese medicine preparation
CN104666494A (en) Eucommia ulmoides moxibustion product and preparation method thereof
CN100333738C (en) Chinese medicinal ointment for treating bone diseases
CN101061975A (en) Medicine mat for preventing and treating cervical vertebrae diseases
CN103550540A (en) Pharmaceutical composition for preventing and treating cervical spondylosis and lumbar spondylosis
CN104474428B (en) A kind of Chinese medicine preparation and preparation method for the treatment of spinal cord injury
CN106177002A (en) A kind of medicated powder medicated wine complex treating bone matrix hyperplasia
CN103055105B (en) Chinese medicinal herb composition for treating orthopedic diseases and preparation method thereof
CN103211900A (en) Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica
CN103083489B (en) Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds
CN103920048A (en) Traditional Chinese medicine plaster for treating ankylosing spondylitis and preparation method thereof
CN103157011B (en) Traditional Chinese medicine composite for promoting fracture healing
CN102872284B (en) Chinese medicinal composition for treating hyperosteogeny and preparation method thereof
CN102133275B (en) Chinese medicine preparation for treating pediatric rubella
CN106237105A (en) A kind of medicated wine treating prolapse of lumbar intervertebral disc, sciatica, rheumatoid arthritis disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130724